DJ Vertex Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 1.24% to $450.46 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.65% to 7,554.29 and the Dow Jones Industrial Average rising 0.92% to 51,671.03.
Vertex Pharmaceuticals Inc. closed 11.31% short of its 52-week high of $507.92, which the company reached on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 2.70% to $221.59, Krystal Biotech Inc. (KRYS) rose 2.13% to $324.75, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 5.16% to $7.33.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 15, 2026 16:39 ET (20:39 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments